HealthcareServices

Minimally Invasive Treatment Of Lung Cancer Market Dynamics 2026: Future Outlook and Key Insights

February 27, 2026March 4, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the minimally invasive treatment of lung cancer market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Minimally Invasive Treatment Of Lung Cancer Market be in 2030 compared with 2026?

The market size for the minimally invasive treatment of lung cancer has demonstrated significant growth over recent years. This market is expected to expand from $3.35 billion in 2025 to $3.67 billion in 2026, achieving a compound annual growth rate (CAGR) of 9.5%. The historical development can be attributed to several factors, including rising lung cancer incidence rates, the proliferation of oncology treatment centers, enhancements in interventional radiology techniques, an increase in the availability of minimally invasive treatment options, and the growing clinical acceptance of ablation therapies.

The market size for the minimally invasive treatment of lung cancer is projected to experience substantial growth in the upcoming years. It is expected to expand to $5.21 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 9.2%. This anticipated expansion during the forecast period is driven by factors such as increasing investments in precision cancer care, the rising adoption of robotic and AI-assisted oncology treatments, the expansion of early-stage lung cancer detection programs, a growing demand for outpatient cancer procedures, and an increasing focus on personalized treatment pathways. Significant trends identified for the forecast period include the increasing adoption of image-guided tumor ablation techniques, a rising use of minimally invasive embolization procedures, the growing integration of robotic assistance in oncology care, the expansion of precision oncology treatment platforms, and an enhanced focus on reducing treatment-related complications.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27349&type=smp

What Drivers Are Guiding Growth Patterns In The Minimally Invasive Treatment Of Lung Cancer Market?

The rising incidence of lung cancer is projected to fuel expansion within the minimally invasive treatment of lung cancer market going forward. Lung cancer, a malignancy originating in the lungs, is characterized by unchecked cellular proliferation. A primary reason for the surge in lung cancer cases is the greater prevalence of tobacco smoking, which heightens the probability of uncontrolled cell growth and subsequent tumor development. Minimally invasive approaches benefit lung cancer patients by targeting, extracting, or eliminating tumors through minor cuts or imaging-guided instruments, thereby shortening recuperation times, lessening harm to healthy lung tissue, reducing complication risks, and enabling patients to resume regular activities sooner. As an illustration, the American Cancer Society, a U.S.-based non-profit organization, reported in January 2023 that an estimated 238,340 individuals, comprising 117,550 men and 120,790 women, are anticipated to be diagnosed with lung cancer in 2023, with approximately 127,070 fatalities expected from the illness. Consequently, the growing occurrence of lung cancer is propelling the growth of the minimally invasive treatment of lung cancer market.

How Is The Minimally Invasive Treatment Of Lung Cancer Market Divided Into Segments?

The minimally invasive treatment of lung cancer market covered in this report is segmented –

1) By Type: Lung Tumor Ablation, Lung Tumor Embolization

2) By Stage: Stage I, Stage II, Stage III, Stage IV

3) By Age Group: Under 30 Years, 31 To 45 Years, 46 To 60 Years

4) By End-User: Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics, Research Institutions

Subsegments:

1) By Lung Tumor Ablation: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Laser Ablation

2) By Lung Tumor Embolization: Bronchial Artery Embolization, Pulmonary Artery Embolization, Chemoembolization, Radioembolization

What Trends Are Expected To Impact The Competitive Landscape Of The Minimally Invasive Treatment Of Lung Cancer Market?

Major companies within the minimally invasive treatment of lung cancer market are focused on developing innovative solutions, such as microwave ablation systems and navigation-assisted biopsy platforms. This effort aims to meet the increasing demand for lung-sparing therapies, faster diagnosis, shorter hospital stays, and viable treatment options for patients who are not candidates for open surgery. Microwave ablation (MWA) devices operate by delivering high-frequency electromagnetic energy through a probe to rapidly heat and coagulate tumor tissue. This creates predictable spherical ablation zones, leading to faster treatment times and a diminished heat-sink effect compared to radiofrequency ablation. For instance, in January 2025, Creo Medical Group plc, a UK-based medical device company specializing in minimally invasive surgical endoscopy, introduced its MicroBlate Flex soft-tissue microwave ablation system and commenced a clinical study for its use in lung lesions. The MicroBlate Flex system is composed of a microwave generator and a flexible ablation applicator, designed for application across numerous soft-tissue indications. It functions by emitting high-frequency microwave energy at the applicator tip to generate controlled thermal zones that destroy tumor cells. The system’s unique features include a high-frequency power profile for efficient energy deposition, a flexible delivery design intended to access challenging anatomies, and compatibility with endoscopic or percutaneous approaches. This enables its application in small pulmonary nodules, metastatic lung lesions, and patients unable to tolerate lobectomy. Clinically, this results in shorter procedure times, a reduced need for general anaesthesia, potential for outpatient workflows, and an expanded set of treatment options when contrasted with open surgery or stereotactic radiotherapy.

Which Key Market Players Are Investing In Expansion And Innovation Within The Minimally Invasive Treatment Of Lung Cancer Market?

Major companies operating in the minimally invasive treatment of lung cancer market are Johnson & Johnson, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Intuitive Surgical Inc., Accuray Incorporated, Richard Wolf GmbH, AngioDynamics Inc., CMR Surgical Ltd., Guangzhou Geyi Medical Instrument Co. Ltd., Quantum Surgical SA, Scanlan International Inc., RZ Medizintechnik GmbH & Co. KG, August Reuchlen GmbH, SBH Surgical GmbH & Co. KG, Geister Medizintechnik GmbH, Cook Medical Incorporated, Terumo Corporation, Merit Medical Systems Inc., Sirtex Medical Limited

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/minimally-invasive-treatment-of-lung-cancer-global-market-report

Which Geographic Areas Are Emerging As Strong Markets For The Minimally Invasive Treatment Of Lung Cancer Market?

North America was the largest region in the minimally invasive treatment of lung cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the minimally invasive treatment of lung cancer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Minimally Invasive Treatment Of Lung Cancer Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27349&type=smp

Browse Through More Reports Similar to the Global Minimally Invasive Treatment Of Lung Cancer Market 2026, By The Business Research Company

Personal Goods Repair And Maintenance Market Report 2026

https://www.thebusinessresearchcompany.com/report/personal-goods-repair-and-maintenance-global-market-report

Consumer Credit Market Report 2026

https://www.thebusinessresearchcompany.com/report/consumer-credit-global-market-report

Credit Card Issuance Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/credit-card-issuance-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795